Ashton Thomas Private Wealth’s 10x Genomics TXG Stock Holding History

Ashton Thomas Private Wealth’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$660K	Sell	17,220 -617	-3%	-$16.2K	0.01%	687
2026 Q1	$379K	Buy	17,837 +2,685	+18%	+$53.7K	0.01%	801
2025 Q4	$247K	Sell	15,152 -6,361	-30%	-$96.1K	0.01%	891
2025 Q3	$251K	Buy	+21,513	New	+$280K	0.01%	850
2024 Q3	–	Sell	-29	Closed	-$564	–	1751
2024 Q2	$564	Buy	+29	New	+$759	﹤0.01%	1892

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ashton Thomas Private Wealth's TXG Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its 10x Genomics (TXG) stake by 3.5% in Q2 2026, selling an estimated $16.2K and leaving 17,220 shares worth $660K. The position accounts for 0.01% of the portfolio, ranked #687.

Ashton Thomas Private Wealth first reported a position in TXG in Q2 2024 and has held it in 5 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Ashton Thomas Private Wealth held 17,220 shares of 10x Genomics worth $660K as of Q2 2026.
Ashton Thomas Private Wealth sold 617 10x Genomics shares in Q2 2026, an estimated $16.2K.
10x Genomics made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #687 holding.
Ashton Thomas Private Wealth first reported a position in 10x Genomics in Q2 2024 and has held it in 5 quarters since.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.